Ken Griffin Astrazeneca PLC Put Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $3.17 Million - $3.63 Million	41,400 Added 14.44%	328,100 $25.6 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $94.2 Million - $114 Million	-1,410,700 Reduced 83.11%	286,700 $22.4 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $47.4 Million - $54 Million	776,900 Added 84.4%	1,697,400 $115 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $30.6 Million - $34.2 Million	-493,900 Reduced 34.92%	920,500 $62 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $19.3 Million - $21.3 Million	297,100 Added 26.59%	1,414,400 $95.8 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $36.3 Million - $39.3 Million	518,800 Added 86.68%	1,117,300 $80 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $653,476 - $740,916	10,348 Added 1.76%	598,500 $41.5 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $13.1 Million - $17 Million	-241,400 Reduced 29.1%	588,152 $39.9 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $4.35 Million - $11.1 Million	82,100 Added 10.98%	829,552 $45.5 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.